These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6299625)

  • 21. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism.
    Anderson JA
    Br J Dermatol; 1978 Nov; 99(5):545-52. PubMed ID: 708628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oestrogen or cyproterone acetate treatment on adrenocortical function in prostate carcinoma patients.
    Schürmeyer T; Graff J; Senge T; Nieschlag E
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):360-7. PubMed ID: 2421511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the cyproterone acetate + ethynil oestradiol antiandrogen association on blood coagulation and fibrinolysis in hirsute women.
    Ghezzo F; Manieri C; Rodi R; Messina M; Molinatti GM
    Panminerva Med; 1981; 23(4):223-6. PubMed ID: 6212899
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
    Seed M; Godsland IF; Wynn V; Jacobs HS
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):689-99. PubMed ID: 6239714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adrenal reactivity to prolonged-action ACTH in hirsute women treated with 50 mg of cyproterone acetate combined with percutaneous estradiol].
    Bercovici JP; Nahoul K; Tater D; Scholler R
    Ann Endocrinol (Paris); 1986; 47(2):115-8. PubMed ID: 3026229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
    Frey H; Aakvaag A
    Acta Obstet Gynecol Scand; 1981; 60(3):295-300. PubMed ID: 6455899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
    Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyproterone acetate and the treatment of hirsutism.
    Fraser IS; Shearman RP; Allen JK; McCarron G
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism.
    Appelt H; Strauss B
    Psychother Psychosom; 1984; 42(1-4):177-81. PubMed ID: 6240068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR; Poznanski N
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyproterone acetate in the treatment of hirsutism.
    Ylöstalo P; Laakso L; Viinikka L; Ylikorkala O; Vihko R
    Acta Obstet Gynecol Scand; 1981; 60(4):399-401. PubMed ID: 7282307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cyproterone acetate on pituitary-adrenocortical function in man.
    van Wayjen RG; van den Ende A
    Acta Endocrinol (Copenh); 1981 Jan; 96(1):112-22. PubMed ID: 6257015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for a non-androgenic anovulant in the management of hirsutism.
    McKenna TJ; Cunningham SK
    Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyproterone acetate for hirsutism.
    Van der Spuy ZM; le Roux PA
    Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism.
    Barnes EW; Irvine WJ; Hunter WM; Ismail AA
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):65-73. PubMed ID: 1122656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P; Mauri M; Gutierrez M
    Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.